- Supplier site
- Group of sites (click to zoom)
Scientist.com supplier network (site locations)
Research supplier
AxioMx
AxioMx is listed as a mid sized business research supplier in the Scientist.com network, with 1 site in 1 country and 1 service area.
Sign in to Scientist.com to open this supplier in your organization's marketplace.
Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Services
What this research supplier says it provides, as listed in the Scientist.com network.
Type of company: Mid sized business
Antibodies
- Custom Antibodies Design and produce polyclonal and monoclonal antibodies.
Protein Sciences
- Phage Display Use in vitro screening method to identify protein binding partners.
Service areas:
Where it operates
Sites by country, with the cities in each.
-
United States 1 site
About this supplier
In the supplier's own words, as listed in the Scientist.com network.
AxioMx applies its novel phage display methods to discovery and develop monoclonal antibodies for research, diagnostic, and therapeutic applications. Our custom antibody services include antigen design, antibody discovery and development, antibody affinity maturation, antibody customization, and protein production. AxioMx is applying knowledge gained from the past 15 years of human genome sequencing to produce highly specific recombinant antibodies against the human proteome. The existing antibody development paradigm is too slow and does not always result in consistent, renewable...
Show the full description
AxioMx applies its novel phage display methods to discovery and develop monoclonal antibodies for research, diagnostic, and therapeutic applications. Our custom antibody services include antigen design, antibody discovery and development, antibody affinity maturation, antibody customization, and protein production.
AxioMx is applying knowledge gained from the past 15 years of human genome sequencing to produce highly specific recombinant antibodies against the human proteome. The existing antibody development paradigm is too slow and does not always result in consistent, renewable, and quality antibodies. Through proprietary advances in traditional phage display antibody library design, phage display screening and affinity maturation technologies, we rapidly generate antibodies at the required binding and specificity criteria. At AxioMx, we believe our platform will lead to the wide adoption of recombinant antibody use in research and diagnostic applications.
- Website
- www.abcam.com
Work with AxioMx on Scientist.com
For prices, more details, or to contact AxioMx, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.